RE:PharmAla to supply the University of Texas, San AntonioI believe these news releases to supply research clinics in the US will continue biweekly to weekly. I would certainly love to see an additional news release in the same week to continue the upward pressure and put some of these penny flippers behind us.
As I mentioned in a past post the unfortunate decision made by the FDA would open the doors for Pharmala in the US for supplying clinical trials. Pharmala's focus has always been supplying outside the US (i.e. Austrialia, Europe and S. America), so when the FDA handed down their decision this became a bonus upside for Phamala. So far... Hopkins, Harvard, San Antonio... and I'm sure more to come.
Pharmala's team is currently in Europe (Oct. 7-11) for the CPHI conference in Milan meeting with a number of potential distribution partners. So we may hear of some possible news from these meetings in the near future.
With these continued news releases the stock should begin a nice steady climb. Depending on how long to the next news release the stock should fine support around the 9-10 cent mark. Until that next news release this may be the last time to pick up shares under 10 cents, as I'm sure TD and CIBC will hammer it back down a bit. Hopefully these shares can find their way into more and more hands of longer term investors, so there will be less and less shares available on the asks and in the hands of the penny flippers.